Abstract Oesophageal adenocarcinoma, a highly fatal cancer, has risen in incidence in Western societies, but it is unclear whether this is due to increasing incidence of its precursor condition, Barrett's oesophagus (BO) or whether the proportion of BO patients undergoing malignant progression has increased in the face of unchanged BO incidence. Data from population-based studies of BO incidence is limited, with equivocal results to date difficult to distinguish from changes in endoscopic practices. The aim of this study was to assess population trends in Barrett's oesophagus (BO) diagnoses in relation to endoscopy and biopsy rates over a 13 year period. The Northern Ireland Barrett's oesophagus Register (NIBR) is a population-based register of all 9,329 adults diagnosed with columnar epithelium of the oesophagus in Northern Ireland between 1993 and 2005, of whom 58.3% were male. European age-standardised annual BO incidence rates were calculated per 100,000 of the population, per 100 endoscopies and per 100 endoscopies including an oesophageal biopsy. Average annual BO incidence rates rose by 159% during the study period, increasing from 23.9/100,000 during 1993-1997 to 62.0/100,000 during 2002-2005. This elevation far exceeded corresponding increases in rates of endoscopies and oesophageal biopsies being conducted. BO incidence increased most markedly in individuals aged\60 years, and most notably amongst males aged \40 years. This study points towards a true increase in the incidence of BO which would appear to be most marked in young males. These findings have significant implications for future rates of oesophageal adenocarcinoma and surveillance programmes.
Oesophageal adenocarcinoma incidence approximately quadrupled in England and Wales between 1971 and 1998 [2] and rates have continued to rise in the past decade [3] . Similar striking increases in oesophageal adenocarcinoma incidence have been observed across many Western societies [1, [4] [5] [6] [7] . Such increases in incidence cannot be entirely attributed to detection bias from improved diagnostic procedures [8] , misclassification bias from reclassification of adjacent gastric cancers [8, 9] , nor overdiagnosis since mortality rates from this cancer have also increased [9] .
It is possible that a rise in Barrett's oesophagus (BO) incidence, the pre-cursor for oesophageal adenocarcinoma, could be accounting for the observed escalating oesophageal adenocarcinoma rates. There is considerable debate over whether there is a true rise in BO incidence in the UK population, or if such an occurrence simply reflects changes in endoscopy practices and improvements in recognition of the disease [10] . One of the major difficulties in accurately assessing BO incidence is a lack of robust population-based data. Many of the studies published to date that have identified increases in clinical BO diagnoses exceeding those of concurrent increased rates of endoscopy and biopsy included only relatively small numbers of BO patients [10] [11] [12] [13] . Nevertheless, a recent national study of BO incidence originating from The Netherlands does suggest an increased incidence of BO over an eleven year period, particularly in younger males who are at a heightened risk of developing oesophageal adenocarcinoma [14] . By contrast two US studies have suggested that the increase they found was largely accounted for by data recording issues [15, 16] . The study conducted in The Netherlands did not have available data on the numbers of endoscopies performed [14] . Therefore, controversy remains as to whether true changes in population BO trends have occurred.
The aim of this investigation was to assess trends in BO incidence in relation to endoscopy and biopsy rates over a thirteen year period using data from the population-based Northern Ireland Barrett's oesophagus register.
Materials and methods

Data collection
The Northern Ireland Barrett's oesophagus register (NIBR) includes all patients diagnosed with BO (defined as columnar-lined oesophagus) in Northern Ireland from January 1993 until December 2005. The NIBR was constructed by performing a standardised review of pathology reports from all oesophageal biopsies conducted in Northern Ireland between 1993 and 2005 (corresponding to SNOMED2 codes T62* and SNOMED3 codes T56*). Any reports diagnosing histologically confirmed columnar epithelium of the oesophagus, or synonymous terms, were deemed to be BO and were eligible for inclusion. Reports relating to the oesophagogastric junction or carcinoma of either the oesophagus or oesophagogastric junction were excluded, as were patients aged \16 years of age. Trained staff extracted information on age, sex, date of BO diagnosis and, where possible, Barrett's segment length from the pathology reports. Data on Barrett's segment length were supplemented by a case note review of medical notes conducted by three trained Tumour Verification Officers from the Northern Ireland Cancer Registry. This case note review was conducted for approximately one-third of NIBR patients who were reported as having specialised intestinal metaplasia. Finally, duplicate biopsies and patients were removed so that only the index BO diagnosis biopsy was retained in the NIBR.
Data on all upper gastrointestinal endoscopies and oesophageal biopsies conducted in Northern Ireland within the same time period were obtained from all public healthcare providers. The largest private healthcare provider contributed endoscopy records from 1998 to 2005, which amounted to only 2% of all endoscopies performed. All electronic data from endoscopy to biopsy reports were received to the Northern Ireland Cancer Registry. Information on other conditions diagnosed at endoscopy, including oesophagitis, gastritis, duodenitis and hiatus hernia, were also recorded. Repeat endoscopies and endoscopies including a biopsy that were performed after a diagnosis of BO were removed from the endoscopy and biopsy datasets. After rigorous electronic and manual resolution, 594 patients in the NIBR could not be matched to any endoscopy records, probably due to name changes or data entry differences, and these patients were added to the endoscopy dataset for completion since they had to have undergone an endoscopy to receive a BO diagnosis.
Ethical approval for the Northern Ireland Barrett's register and related research has been granted by the regional ethics committee of Northern Ireland.
Statistical analysis
Annual European age-standardised incidence rates of BO were calculated per 100,000 of the Northern Ireland population using mid-year population estimates (Northern Ireland Statistics and Research Agency). European agestandardisation was conducted using standard methods as outlined by the International Agency for Research on Cancer [17] . For comparison purposes, incidence rates of oesophagitis, gastritis, duodenitis and hiatus hernia per 100,000 of the population were also calculated. To determine BO incidence in relation to endoscopy rates, firstly the annual number of endoscopies (excluding repeat endoscopies after a BO diagnosis) in Northern Ireland were calculated per 100,000 of the population and age-standardised according to European rates. Annual BO incidence was then divided by endoscopy rates and multiplied by 100 to give BO incidence per 100 endoscopies performed. BO incidence per 100 endoscopies that included oesophageal biopsies (hereafter referred to as BO incidence per 100 biopsies) was calculated in a similar way. Incidence rates are also presented in three time bands to maximise comparability with other published population-based estimates of BO incidence [14] . Stratified analyses were conducted according to gender, age groupings, deprivation quintiles and BO segment length although results are not presented for the latter as segment length was unknown for two-thirds of patients. Comparisons between characteristics in BO patients were performed using independent t-tests or chisquared tests, as appropriate. Poisson regression was applied to assess trends in BO incidence over time. All data cleaning and statistical analyses were conducted using Microsoft Office Excel 2007 and Intercooled Stata version 11.0 (College Station, Texas, USA).
Results
Over the 13 year time period in Northern Ireland, 261,725 endoscopies of the upper gastrointestinal tract were conducted and 24,876 of these included oesophageal biopsies (excluding repeat endoscopies and biopsies performed after a BO diagnosis). This corresponded to 197,635 unique patients who underwent an endoscopy, and resulted in 9,329 individuals aged C16 years being diagnosed with BO.
Males accounted for 58.3% of BO patients, and were significantly younger than females at the time of BO diagnosis ( Table 1) . Overall mean age of BO diagnosis declined from 61.9 years in 1993-1997 to 60.4 years in [2002] [2003] [2004] [2005] . As shown in Table 1 , BO segment length was unknown for the majority of patients.
As shown in Fig. 1 , European age-standardised BO incidence rates increased steadily from 1993 to 2003, with a sharp rise observed in 2000 followed by a slight downturn in the latter 2 years. These patterns of BO diagnoses closely paralleled trends in endoscopy and, particularly, oesophageal biopsy rates. Overall increases in BO incidence were evident for both males and females, although rates were consistently higher in males, and were universal across categories of deprivation (data not shown). However, the simultaneous increase in endoscopy and biopsy rates do not appear to explain all of the observed increase in BO diagnoses. As shown in Table 2 , average annual BO incidence rates rose by 159%, increasing from 23.9/ 100,000 during 1993-1997 to 62.0/100,000 during 2002-2005. Over the same time period, there were only 35 and 45% corresponding increases in all endoscopies and in endoscopies that included oesophageal biopsies, respectively (Table 2) . Even with somewhat increasing rates of endoscopy and biopsy, BO was still diagnosed more frequently per 100 endoscopies and per 100 biopsies in 2002-2005 compared with earlier time periods. The marked elevation in BO incidence also far exceeds that of other upper gastrointestinal disorders diagnosed per 100,000 of the population between 1993 and 2005, for example oesophagitis rose by 33%, hiatus hernia increased by 62%, and gastritis and duodenitis increased by 70% (Fig. 2) .
When examining endoscopy patterns in Northern Ireland, across all three time bands females underwent more endoscopies than males (Table 2) . However, BO incidence per 100 endoscopies was almost twice as high in males compared with females. In contrast, males were more Figure 3 illustrates the percentage change in BO incidence per 100,000 population by age categories in 2002-2005 compared with 1993-1997. Increases in BO incidence were observed universally across age categories and between sexes, but were more marked in \60 year age categories. A particularly large 236% increase in BO incidence was noted amongst males aged\40 years, which was not apparent in females of that age group. However, there were relatively few male BO patients in this age group (as shown in 
Discussion
This study demonstrates that BO incidence rates have risen in the Northern Ireland population, and although diagnosis rates reflect changes in endoscopy and oesophageal biopsy rates, the latter do not fully account for the larger increase in BO incidence. Furthermore, rising BO incidence rates were particularly striking amongst younger males.
Between 1993-1997 and 2002-2005 there was a 159% increase in BO incidence, corresponding to an increase in the frequency of BO detection per 100,000 of the population from 1/51 individuals to 1/21 individuals over the 13 year period. A similar population-based study from the Netherlands also noted an increase in BO of 41% in males and 23% in females over a 12 year period [14] . That study was based on histology and could not comment on whether Fig. 1 European age-standardised Barrett's oesophagus incidence in relation to endoscopy and oesophageal biopsy rates in Northern Ireland. EASR BO European age-standardised rate of Barrett's oesophagus or not rising endoscopy rates could be the sole explanation for the rise in BO. A small study of 260 cases of BO, also from the Netherlands, suggested that the rise was real and not solely explained by endoscopy rates [13] , although other International data have not supported this [15, 16] . Both of the latter studies were based in the USA, one of which found that overall BO incidence did not significantly alter between 1996 and 2002 [15] , while another also observed largely unchanged BO incidence rates from 1998 until 2004 and attributed increases in incidence in 2005 and 2006 to data collection biases, even when accounting for endoscopy volumes in the study region [16] . Unlike the current analysis, none of the above studies were able to explore population-based BO incidence rates in relation to both endoscopy and oesophageal biopsy rates [13] [14] [15] [16] . Our data, based on over 9,000 cases, do indicate an increase in BO diagnosis significantly greater than the 35% increase in endoscopy rates over the same period. We were also able to demonstrate that the increase in incidence of other diagnoses made at endoscopy, for example oesophagitis, corresponded to similar changes in endoscopy rate and were considerably less than the observed rate of BO incidence increase. This suggests that the BO increase is not part of a general diagnosis inflation, where all oesophageal conditions would be expected to be diagnosed more frequently and reported to a similar degree. The slight downturn in BO and endoscopy rates in 2004-2005 is difficult to explain, although updated guidelines for the diagnosis of BO were published in 2005 by the British Society of Gastroenterology [18] and may have altered the behaviour of endoscopists and histopathologists, although it is unlikely this would have impacted on incidence rates so quickly. Until further data is available for later years we can only currently interpret this downturn as an anomaly, although it may represent a plateau in clinical BO diagnoses. A similar plateau has been also been observed in recent data from Olmsted County, USA, [19] suggesting that the increase in BO incidence may have peaked.
One of the key pieces of data from our study is the rate of BO diagnosis per endoscopic biopsy. Between 1993-1997 and 2002-2005, overall BO incidence increased from being detected in a fifth of oesophageal biopsies to a third of biopsies. There are several potential explanations for this finding. Firstly, there could be a true increase in BO (which is being biopsied) associated with a smaller decline in non-BO oesophageal biopsies. Secondly, endoscopists could be targeting the oesophagus differently and choosing to biopsy short segments of BO that they previously would have ignored and are no longer biopsying normal oesophagus. This is supported by an Australian study that showed a very large increase in short segment BO and an actual decrease in long segment BO [12] . Due to the large number of unknown BO length in our cohort, this cannot be stated with absolute certainty, however our limited data showed an increase in both long and short segment BO cases suggesting that the overall increase is at least partially reflecting a true rise in BO diagnoses in the population. Thirdly, it is plausible that endoscopists and histopathologists may have reduced their threshold for making a diagnosis of BO or are looking more carefully for it due to increased awareness of the disease in recent years [10] .
The age and gender specific data are important and may point towards a true increase of BO being the correct interpretation. It could be interpreted that this study provides some evidence that physicians appear to be better targeting females since the elevation in BO diagnosed per biopsy was twice that of the increase in biopsy rates. However, the greatest increase in BO diagnosis was in the under-60 year age categories for both sexes, which is consistent with the findings of Post et al. in the Netherlands [14] . Moreover, BO incidence was consistently higher in males, which could possibly be attributed to patterns of obesity and central adiposity in the population [20, 21] . Indeed, there is a gender discrepancy in the under-40 year age group with a large increase in BO diagnosis among males and less so among females. This would be consistent with the known older presentation of BO in females that is demonstrated in both the current study and other smaller published studies [13, 22] . These age and gender differences make altered endoscopic behaviour or altered histopathology reporting less likely explanations for the increase, as neither of these would be expected to apply differentially across age groups or gender. If our data do represent a true increase, this has implications for a potentially increasing pool of individuals at risk of OAC in the coming decades especially as the largest percentage increase in BO diagnosis was in the youngest group of males. Moreover, results from this study also indicate that mean age of BO diagnosis is declining, which is consistent with other reports from the UK [23] , fuelling concerns over possible future rises in oesophageal adenocarcinoma incidence in a younger population. Two important strengths of this study are its size and the fact that it is a comprehensive, population-based analysis of a relatively stable community. Through the NIBR we have been able to capture all diagnoses of BO within a single geographic location, allowing accurate comments to be made regarding the emerging pattern of BO incidence. Another major strength of this study is the accountability of both endoscopy and oesophageal biopsy rates in our calculations of BO incidence. One issue which needs to be taken into account when comparing BO incidence in our study with others is that Northern Ireland has a higher rate of endoscopy compared with the rest of the UK (12.5 v. 8/1,000 population per year) (R. Hulatt, personal communication). Therefore, the generalisability of our findings with BO incidence in other populations may be limited. We were also unable to match 594 BO patients to their initial endoscopy records, and so added them into the endoscopy dataset, which may have artificially inflated the number of endoscopies performed over this time period slightly, however these patients only accounted for 6% of all BO patients, and therefore any potential dilution effect on BO rates per endoscopy is minimal. In addition, despite the thorough analysis of endoscopy and biopsy data we are unable to account for any changes in BO detection due to increased awareness of the condition amongst practitioners. We were also unable to obtain information on BO segment length for a substantial proportion of patients therefore analysis into increases in short v. long segment BO was limited.
In conclusion, this large population-based study provides evidence pointing towards a true increase in the incidence of BO which would appear to be most marked in young males. These findings have significant implications for future rates of oesophageal adenocarcinoma and increased demand on surveillance programmes. Future research should be directed towards identifying factors that may reduce BO incidence in the population and minimise the proportion of these patients that will undergo malignant progression.
